Malignant Brain Tumor
16
4
4
7
Key Insights
Highlights
Success Rate
64% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 74/100
25.0%
4 terminated out of 16 trials
63.6%
-22.9% vs benchmark
0%
0 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (16)
Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients
NeuroPathways Intervention for Brain Tumor Patients
Evaluation of cCeLL-Ex Vivo Confocal Microscopy for Real-time Brain Tumor Diagnosis
Evaluation of the Contribution of NODDI Protocol Tractography in Brain Tumor Surgery
Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease
ASCENT Intervention for Brain Tumor Patients
Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors
Psychological Intervention For Brain Tumor Caregivers
Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
Rates DMBT1 ( Glycoprotein) in Sputum of CF Patients With Pseudomonas Aeruginosa
Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
National Wide Cross-sectional Study in Paediatric Central Nervous System Tumours in China -- the CNOG-MC001 Registry
Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors
A Computer-Based Intervention for Distance Caregivers of Parents With Advanced Cancer
Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma